Nudging Flu Vaccination by Making it Easy for Patients to Schedule a Flu Shot
Sponsored by Geisinger Clinic
About this trial
Last updated 3 years ago
Study ID
Status
Type
Phase
Placebo
Accepting
Not accepting
Trial Timing
Ended 3 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- Included in one or both of the following two base patient lists:
- Aged 18 or older as of October 2022
- Has had a Geisinger encounter in the last 2 years as of October 2022
- Either of the following, as of October 2022:
- Has not received a flu-shot during the 2022-23 flu season as of ~1 week prior to the message date (timeline may be slightly different, depending on data pull logistics), according to the Electronic Health Record (EHR)
- Does not have a scheduled in-person primary care or in-person flu-shot-eligible specialty appointment in the 12 weeks following their assigned message send date, as of ~1 week prior to the message date (timelines may be slightly different, depending on data pull logistics or clinical guidance)
Exclusion Criteria
- The CMSL/Marketing list will include patients in Geisinger's 65Forward or Community Care populations. If necessary due to logistical constraints, we may exclude these 65Forward and/or Community Care patients from our study.
- Cannot be contacted via the communication modality being used in the study (e.g., patient portal, SMS), e.g., due to insufficient/missing contact information in the EHR or because they opted out
- Has an allergy to flu vaccines according to any EHR allergy table known to the study team
- Has a health maintenance modifier indicating they are permanently discontinued from receiving a seasonal flu shot
- Is on a list of dismissed patients